Surmodics | SRDX - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Abbott USD 29.64B 19.74B 2026-03
Align Technology USD 0 0 2024-12
Arrowhead Research USD 1.23B 687.3M 2026-03
Artivion USD 215.35M 2.46M 2026-03
Baxter International USD 8.62B 852M 2026-03
Boston Scientific USD 11.01B 19M 2025-12
EDAP TMS EUR 1.01M 13K 2025-09
Edwards Lifesciences USD 600M 1.7M 2026-03
Haemonetics USD 1.22B 299.58M 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
J&J USD 37.53B 1.91B 2026-03
Merit Medical Systems USD 735.16M 1.12M 2026-03
Mesa Laboratories USD 104.2M 104.3M 2024-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Option Care Health USD 1.15B 1.01M 2026-03
Stryker USD 14.22B 635M 2026-03
Surmodics USD 29.67M 116K 2025-06
Trinity Biotech USD 114.86M 4.81M 2025-09